Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

The Tumour Immune Microenvironment in Breast Ductal Carcinoma In Situ Progression to Invasive Cancer

FY 2018-19

Summary
Ductal carcinoma in situ (DCIS) comprises around 20% of all breast cancer diagnoses. DCIS, which can be considered as “stage 0 breast cancer”, is a collection of abnormal cells lining the ducts of breast tissue and has been shown to increase the likelihood of developing more aggressive and invasive tumours. Not all DCIS progresses to invasive breast cancer, however as of yet there remains no clear method of determining which DCIS lesions are most likely to become invasive, therefore the standard is to treat all patients with wide-local excision surgery, followed by radiotherapy. Thus, there is an urgent need to better be able to predict and prevent disease progression, in order to reduce over-treatment of DCIS. My proposed research is focused on ways to better predict the progression of DCIS and the role of the immune system in tumour growth. The immune system is activated during early cancer development, in an effort to eliminate abnormal cancer cells, but during more advanced stages the immune system is suppressed, and cancer cells tend to acquire the ability to evade immune system surveillance. This process is called immunoediting. Using a DCIS mouse model, I plan to look at how the process of immunoediting can be interrupted, by promoting an overall more activated immune microenvironment. I will also evaluate human paired DCIS and invasive breast cancer tissue using imaging mass cytometry, to gain a more comprehensive overview of the immune microenvironment and how it changes with invasion. The results obtained from this project will contribute to a better understanding of how the immune system modulates breast cancer progression and how this can be used to treat patients with DCIS more appropriately.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
406635
Name
Francis Alyssa V
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Tumour Immune Microenvironment in Breast Ductal Carcinoma In Situ Progression to Invasive Cancer
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Breast Cancer; Dcis; Immune System; Macrophages; Microenvironment; T Cells
Abstract
Ductal carcinoma in situ (DCIS) comprises around 20% of all breast cancer diagnoses. DCIS, which can be considered as “stage 0 breast cancer”, is a collection of abnormal cells lining the ducts of breast tissue and has been shown to increase the likelihood of developing more aggressive and invasive tumours. Not all DCIS progresses to invasive breast cancer, however as of yet there remains no clear method of determining which DCIS lesions are most likely to become invasive, therefore the standard is to treat all patients with wide-local excision surgery, followed by radiotherapy. Thus, there is an urgent need to better be able to predict and prevent disease progression, in order to reduce over-treatment of DCIS. My proposed research is focused on ways to better predict the progression of DCIS and the role of the immune system in tumour growth. The immune system is activated during early cancer development, in an effort to eliminate abnormal cancer cells, but during more advanced stages the immune system is suppressed, and cancer cells tend to acquire the ability to evade immune system surveillance. This process is called immunoediting. Using a DCIS mouse model, I plan to look at how the process of immunoediting can be interrupted, by promoting an overall more activated immune microenvironment. I will also evaluate human paired DCIS and invasive breast cancer tissue using imaging mass cytometry, to gain a more comprehensive overview of the immune microenvironment and how it changes with invasion. The results obtained from this project will contribute to a better understanding of how the immune system modulates breast cancer progression and how this can be used to treat patients with DCIS more appropriately.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Francis, Alyssa V
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~